NEUES

NEUES is a Japan-based site management organization (SMO) that supports the execution of clinical trials at medical institutions. The company provides site selection and qualification, trial coordination, investigational review board support, and broader site management services for sponsors and study sites. NEUES was founded in 1996 and became part of M3 through a December 2014 acquisition, strengthening M3's clinical trial services footprint in Japan. It has operated as one of the larger SMO providers in the Japanese market, with a nationwide office network and extensive affiliated medical institutions. NEUES appears to be a services company rather than a therapeutic-product developer, so it does not have a conventional drug pipeline.